Picture of Theradiag SA logo

ALTER Theradiag SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapFalling Star

Brief: Theradiag H1 Net Result Turns To Loss Of EUR 229,000

Sept 21 (Reuters) - Theradiag SA  ALTHE.PA :
    * H1 REVENUE 4.9 MILLION EUR VERSUS 5.0 MILLION EUR YEAR AGO
    * H1 NET LOSS -229,000 EUR VERSUS 727,000 EUR PROFIT YEAR
AGO
    * CONTINUED INVESTMENT IN RESEARCH AND DEVELOPMENT TO DRIVE
FUTURE
GROWTH
    * H1 OPERATING LOSS EUR 0.4 MILLION VERSUS LOSS OF EUR 0.2
MILLION
(REPORTED) YEAR AGO
    * AT JUNE 30, 2020, NET CASH STOOD AT EUR 1.7 MILLION,
COMPARED TO
EUR 2.9 MILLION AT DECEMBER 31, 2019
    * SEES LIKELY IMPACT OF AROUND 10% ON 2020 FULL-YEAR
REVENUE.
    * WILL DO ITS UTMOST TO STAY COURSE, MEET ITS FINANCIAL
TARGETS
AND RETURN TO BREAKEVEN OVER A PERIOD EXTENDED UNTIL 2021

Source text for Eikon:  ID:nBw2BCwG5a 
Further company coverage:  ALTHE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Theradiag SA

See all news